Capstone Investment Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,339,800
Closed -$133M 1519
2019
Q3
$133M Buy
1,339,800
+442,000
+49% +$42M 0.91% 18
2019
Q2
$83M Buy
897,800
+634,800
+241% +$60.3M 0.6% 27
2019
Q1
$24.8M Buy
263,000
+194,800
+286% +$17M 0.23% 101
2018
Q4
$4.37M Buy
68,200
+11,100
+19% +$819K 0.05% 274
2018
Q3
$5.11M Sell
57,100
-91,100
-61% -$8.05M 0.06% 249
2018
Q2
$11.8M Buy
+148,200
New +$12.3M 0.18% 88
2018
Q1
Sell
-1,300
Closed -$134K 626
2017
Q4
$134K Hold
1,300
﹤0.01% 455
2017
Q3
$189K Hold
1,300
0.01% 487
2017
Q2
$167K Sell
1,300
-11,900
-90% -$1.46M ﹤0.01% 577
2017
Q1
$1.64M Sell
13,200
-7,300
-36% -$874K 0.04% 324
2016
Q4
$2.37M Buy
+20,500
New +$2.28M 0.07% 245
2014
Q1
Sell
-3,800
Closed -$321K 608
2013
Q4
$321K Hold
3,800
﹤0.01% 445
2013
Q3
$292K Buy
+3,800
New +$266K ﹤0.01% 481

Other funds holding CELG

Capstone Investment Advisors's CELG Position: Q4 2019 in Review

Capstone Investment Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,342,761 shares — an estimated $133M sold.

Capstone Investment Advisors first reported a position in CELG in Q3 2013 and held it in 14 quarters. The position peaked at $133M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Capstone Investment Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Capstone Investment Advisors sold 1,342,761 Celgene Corp shares in Q4 2019, an estimated $133M.
  • Capstone Investment Advisors first reported a position in Celgene Corp in Q3 2013 and held it in 14 quarters.
  • Capstone Investment Advisors's Celgene Corp position peaked at $133M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Capstone Investment Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.